Question: I am a woman with a BMI of 31 and have recently been put on statins for high cholesterol. I have also been told ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

Ozempic is already approved to treat T2D, for cardiovascular risk reduction in T2D patients, and to prevent worsening kidney disease and cardiovascular death in people with T2D and CKD.

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

GLP-1 drugs like Ozempic® and Zepbound®, have gained significant attention in recent years for treating both diabetes and ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...

At first, Chinese pharmaceutical companies rushed to make similar versions of blockbuster weight-loss drugs, such as Wegovy and Ozempic, that have taken the world by storm ... such as sleep apnoea, ...

Pharma giants are sweating on the results of a federal government request for guidance on adding weight loss drugs to the ...